Advertisement
Advertisement
CMMB
Chemomab Therapeutics Ltd. - ADR
1.89
USDSponsored
-0.04
-2.07%
Aug 10, 15:59 UTC -4
Closed
After-Market
1.87
-0.02
-1.06%
CMMB Earnings Reports
Positive Surprise Ratio
CMMB beat 4 of 22 last estimates.
18%
Next Report
In 2 Days
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.15
Implied change from Q1 26 (Revenue/ EPS)
--
/-37.50%
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Chemomab Therapeutics Ltd. - ADR earnings per share and revenue
On May 14, 2026, CMMB reported earnings of -0.24 USD per share (EPS) for Q1 26, missing the estimate of -0.15 USD, resulting in a -51.80% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.30% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.15 USD, with revenue projected to reach -- USD, implying an decrease of -37.50% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Passage Bio, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$2.69
Actual
-$2.44
Surprise
+9.62%
Axsome Therapeutics, Inc
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.86
Actual
-$0.99
Surprise
-14.90%
Apogee Therapeutics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$1.09
Actual
-$1.13
Surprise
-4.39%
Biohaven Ltd.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.74
Actual
-$0.91
Surprise
-21.67%
Septerna, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.43
Actual
-$0.28
Surprise
+33.26%
Olema Pharmaceuticals, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.55
Actual
-$0.61
Surprise
-9.83%
Sana Biotechnology, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.13
Surprise
+12.58%
Enanta Pharmaceuticals, Inc
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.52
Actual
-$0.67
Surprise
-28.80%
Orchestra BioMed Holdings, Inc. Ordinary Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.39
Actual
-Surprise
-
Entera Bio Ltd. Ordinary Shares
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.14
Surprise
-71.57%
FAQ
What were Chemomab Therapeutics Ltd. - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Chemomab Therapeutics Ltd. - ADR reported EPS of -$0.24, missing estimates by -51.8%, and revenue of $0.00, 0% as expectations.
How did the market react to Chemomab Therapeutics Ltd. - ADR's Q1 2026 earnings?
The stock price moved down -2.3%, changed from $1.74 before the earnings release to $1.70 the day after.
When is Chemomab Therapeutics Ltd. - ADR expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Chemomab Therapeutics Ltd. - ADR's next earnings report?
Based on 3
analysts, Chemomab Therapeutics Ltd. - ADR is expected to report EPS of -$0.15 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement